Gencell Ltd (TLV:GNCL)
Israel · Delayed Price · Currency is ILS · Price in ILA 66.50
-2.90 (-4.18%)
Oct 1, 2026, 2:24 PM IDT
Gencell Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.41 | 6.08 | 34.78 | 17.52 | 26.03 | 17.24 | |
Revenue Growth | -86.96% | -82.53% | 98.56% | -32.71% | 51.02% | 1554.89% |
Cost of Revenue | 9.39 | 25.96 | 38.23 | 36.14 | 35.35 | 26.46 |
Gross Profit | -4.98 | -19.89 | -3.45 | -18.62 | -9.32 | -9.22 |
Selling, General & Admin | 15.16 | 29.33 | 36.19 | 40.4 | 40.19 | 36.56 |
Research & Development | 2.83 | 14.16 | 30.28 | 47.57 | 27.62 | 17.74 |
Operating Expenses | 17.99 | 43.49 | 66.48 | 87.96 | 67.82 | 54.3 |
Operating Income | -22.97 | -63.37 | -69.92 | -106.58 | -77.14 | -63.52 |
Interest Expense | -0.73 | -0.25 | -0.62 | -0.69 | -0.77 | -2.45 |
Interest & Investment Income | 0.07 | 1.03 | 5.84 | 11.57 | 8.81 | 1.09 |
Currency Exchange Gain (Loss) | 1 | 1.07 | 0.96 | 0.97 | -10.14 | 0.41 |
Other Non Operating Income (Expenses) | -0.7 | -0.81 | 2.74 | -0.81 | 3.21 | -0.93 |
EBT Excluding Unusual Items | -23.33 | -62.33 | -61.01 | -95.54 | -76.04 | -65.39 |
Gain (Loss) on Sale of Assets | -13.35 | -14.8 | -0.13 | - | - | - |
Asset Writedown | 15.21 | 17.05 | -9.37 | -6.18 | -52.26 | - |
Pretax Income | -21.47 | -60.08 | -70.51 | -101.72 | -128.29 | -65.39 |
Income Tax Expense | 0.01 | 0.18 | 0.27 | 0.21 | 0.67 | 0.2 |
Net Income | -21.48 | -60.27 | -70.78 | -101.92 | -128.96 | -65.6 |
Net Income to Common | -21.48 | -60.27 | -70.78 | -101.92 | -128.96 | -65.6 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 33 | 22 | 22 | 22 | 22 | 19 |
Shares Outstanding (Diluted) | 33 | 22 | 22 | 22 | 22 | 19 |
Shares Change | 50.39% | 1.95% | 1.24% | 0.14% | 13.67% | 424.33% |
EPS (Basic) | -0.65 | -2.71 | -3.25 | -4.73 | -6.00 | -3.47 |
EPS (Diluted) | -0.65 | -2.71 | -3.25 | -4.73 | -6.00 | -3.47 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -14.2 | -29.71 | -69.48 | -98.53 | -84.55 | -44.99 |
Free Cash Flow Per Share | -0.43 | -1.34 | -3.19 | -4.58 | -3.93 | -2.38 |
Gross Margin | -112.91% | - | -9.92% | -106.29% | -35.81% | -53.50% |
Operating Margin | -520.88% | -1042.97% | -201.05% | -608.45% | -296.34% | -368.50% |
Profit Margin | -487.05% | -991.82% | -203.52% | -581.87% | -495.42% | -380.55% |
Free Cash Flow Margin | -321.92% | -488.93% | -199.78% | -562.48% | -324.80% | -260.99% |
EBITDA | -24.48 | -59.78 | -69.08 | -105.12 | -76.88 | -62.16 |
EBITDA Margin | - | - | -198.62% | - | -295.34% | - |
D&A For EBITDA | -1.51 | 3.59 | 0.85 | 1.46 | 0.26 | 1.36 |
EBIT | -22.97 | -63.37 | -69.92 | -106.58 | -77.14 | -63.52 |
EBIT Margin | - | - | -201.05% | - | -296.34% | - |
Advertising Expenses | - | 0.22 | 2.66 | 3.32 | 2.28 | 0.92 |